For some older adults, the flu vaccine could look a little different this year. In August, the US Food and Drug ...
Moderna (MRNA) reached a 52-week high as CEO Bancel emphasized the company's mRNA platform capabilities beyond COVID vaccines, spotlighting cancer treatment.
Moderna's 177% stock surge followed its mRNA cancer vaccine success, but CEO Stéphane Bancel says China's biotechnology investments pose a threat.
7hon MSN
Penn helped test a promising mRNA cancer vaccine. Here’s what the trial means for the field
PHILADELPHIA -- Denise Fitzsimmons knew that removing the fast-growing lump above her eyebrow in 2024 didn’t eliminate the ...
Moderna’s share price popped in August on positive news about its therapeutic cancer vaccine to prevent melanoma from ...
Doses of Moderna’s mFlusiva are available at CVS. Walgreens expects to begin receiving shipments of the vaccine any day now.
Add Yahoo as a preferred source to see more of our stories on Google. A Moderna logo is displayed on a building in Cambridge, Massachusetts, on Sept. 5, 2024. The Food and Drug Administration has ...
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7.1% in the afternoon session after the company presented at the ...
Good morning, and good afternoon for those of you that are following us from overseas. Thank you so much for joining us today. On behalf of my colleagues and I, welcome to Moderna's Science Day 2026.
Learn who is eligible for the new flu vaccine and what makes the mRNA vaccine more efficient and adaptable than traditional flu shot.
Presidential Symposium: * LBA1- INTerpath-001: Phase 3 study of the mRNA-based individualized neoantigen therapy (INT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results